Enhancing the Clinical Value of Medical Laboratory Testing

Overview

Journal Clin Biochem Rev

Specialty Biochemistry

Date 2018 Jan 16

PMID 29332975

Citations 23

Authors

Kenneth A Sikaris

Affiliations

Soon will be listed here.

Abstract

The value of medical laboratory testing is often directed to the cost of testing however the clinical benefits of these tests are at least as important. Laboratory testing has an acknowledged widespread role in clinical decision making, and therefore a role in determining clinical outcome. Consequently, the value of laboratory testing should be considered in its role in affecting beneficial actions and outcomes. This includes both the requesting phase of choosing tests which will influence clinical decision making as well as the reporting phase in a way that guides clinical decisions and actions. Clinical decision support systems and software can enhance the value of medical laboratory testing if they are directed toward facilitating those clinical decisions where there is either evidence, or agreed consensus, addressing patient outcomes.

Citing Articles

Assessing customer satisfaction: the case of test prescribers at the clinical biology laboratory of Centre Muraz/ Institut National de Santé Publique, Burkina Faso.

Yenyetou D, Sanou I, Thiombiano C, Sogodogo B, Sanou A, Sanou S BMC Health Serv Res. 2025; 25(1):112.

PMID: 39833794 PMC: 11748244. DOI: 10.1186/s12913-025-12260-4.

Links between accuracy and effectiveness of laboratory medicine equipment: use of the EUnetHTA core model to compare two analyzers by measuring HbA1c.

Di Resta C, Sacco C, Trbos M, Locatelli M, Banfi G, Tomaiuolo R Int J Technol Assess Health Care. 2024; 40(1):e67.

PMID: 39623926 PMC: 11703618. DOI: 10.1017/S0266462324000497.

Enterprise risk management implementation challenges in medical laboratories in Harare, Zimbabwe.

Vhanda D, Chinowaita K, Chinowaita F, Vhanda R, Nherera B, Dzinamarira T Health Sci Rep. 2024; 7(9):e70088.

PMID: 39319251 PMC: 11420288. DOI: 10.1002/hsr2.70088.

Private Doctors' Perspective towards "Patient First" in TB Diagnostic Cascade, Hisar, India.

Saini S, Prasad B, Mahajan A, Duhan A, Jangra A, Gauttam J Diagnostics (Basel). 2024; 14(11).

PMID: 38893690 PMC: 11171542. DOI: 10.3390/diagnostics14111164.

Antiphospholipid antibodies in patients with antiphospholipid syndrome.

Dodig S, cepelak I Biochem Med (Zagreb). 2024; 34(2):020504.

PMID: 38882589 PMC: 11177653. DOI: 10.11613/BM.2024.020504.

References

Szajewska H . Clinical practice guidelines: based on eminence or evidence?. Ann Nutr Metab. 2014; 64(3-4):325-31. DOI: 10.1159/000365041. View

van der Weijden T, van Bokhoven M, Dinant G, van Hasselt C, Grol R . Understanding laboratory testing in diagnostic uncertainty: a qualitative study in general practice. Br J Gen Pract. 2003; 52(485):974-80. PMC: 1314466. View

Sandberg S, Fraser C, Horvath A, Jansen R, Jones G, Oosterhuis W . Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2015; 53(6):833-5. DOI: 10.1515/cclm-2015-0067. View

Plebani M . Test utilization is a quality control issue. Am J Clin Pathol. 2015; 143(6):910-1. DOI: 10.1309/AJCPINW7ZL1UJWSD. View

Hauser R, Shirts B . Do we now know what inappropriate laboratory utilization is? An expanded systematic review of laboratory clinical audits. Am J Clin Pathol. 2014; 141(6):774-83. DOI: 10.1309/AJCPX1HIEM4KLGNU. View

Gottheil S, Khemani E, Copley K, Keeney M, Kinney J, Chin-Yee I . Reducing inappropriate ESR testing with computerized clinical decision support. BMJ Qual Improv Rep. 2016; 5(1). PMC: 4822023. DOI: 10.1136/bmjquality.u211376.w4582. View

Williams A . Cost-effectiveness analysis: is it ethical?. J Med Ethics. 1992; 18(1):7-11. PMC: 1376077. DOI: 10.1136/jme.18.1.7. View

Poley M, Edelenbos K, Mosseveld M, van Wijk M, de Bakker D, van der Lei J . Cost consequences of implementing an electronic decision support system for ordering laboratory tests in primary care: evidence from a controlled prospective study in the Netherlands. Clin Chem. 2006; 53(2):213-9. DOI: 10.1373/clinchem.2006.073908. View

Bridges S, Papa L, Norris A, Chase S . Duplicated laboratory tests: evaluation of a computerized alert intervention abstract. J Healthc Qual. 2012; 36(3):46-53. DOI: 10.1111/j.1945-1474.2012.00219.x. View

10.

Vasikaran S, Sikaris K, Kilpatrick E, French J, Badrick T, Osypiw J . Assuring the quality of interpretative comments in clinical chemistry. Clin Chem Lab Med. 2016; 54(12):1901-1911. DOI: 10.1515/cclm-2016-0709. View

11.

Salinas M, Lopez-Garrigos M, Flores E, Uris J, Leiva-Salinas C . Larger differences in utilization of rarely requested tests in primary care in Spain. Biochem Med (Zagreb). 2015; 25(3):410-5. PMC: 4622187. DOI: 10.11613/BM.2015.041. View

12.

Leurquin P, Van Casteren V, De Maeseneer J . Use of blood tests in general practice: a collaborative study in eight European countries. Eurosentinel Study Group. Br J Gen Pract. 1995; 45(390):21-5. PMC: 1239108. View

13.

Plebani M, Sciacovelli L, Aita A, Pelloso M, Chiozza M . Performance criteria and quality indicators for the pre-analytical phase. Clin Chem Lab Med. 2015; 53(6):943-8. DOI: 10.1515/cclm-2014-1124. View

14.

Fraser C, Kallner A, Kenny D, PETERSEN P . Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest. 2000; 59(7):477-8. View

15.

van Bokhoven M, Koch H, Dinant G, Bindels P, Grol R, van der Weijden T . Exploring the black box of change in improving test-ordering routines. Fam Pract. 2008; 25(3):139-45. DOI: 10.1093/fampra/cmn022. View

16.

Jones G, Sikaris K, Gill J . 'Allowable Limits of Performance' for External Quality Assurance Programs - an Approach to Application of the Stockholm Criteria by the RCPA Quality Assurance Programs. Clin Biochem Rev. 2012; 33(4):133-9. PMC: 3529550. View

17.

Haggerty J, Tudiver F, Brown J, Herbert C, Ciampi A, Guibert R . Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests. Can Fam Physician. 2006; 51:1658-9. PMC: 1479496. View

18.

Sikaris K . Performance criteria of the post-analytical phase. Clin Chem Lab Med. 2015; 53(6):949-58. DOI: 10.1515/cclm-2015-0016. View

19.

Larsson A . What can we learn from studies on regional differences in the utilization of laboratory tests?. Ups J Med Sci. 2011; 116(4):225-6. PMC: 3207296. DOI: 10.3109/03009734.2011.624281. View

20.

Sikaris K . Application of the stockholm hierarchy to defining the quality of reference intervals and clinical decision limits. Clin Biochem Rev. 2012; 33(4):141-8. PMC: 3529551. View